Obesidad, diabetes, cognición y enfermedades CV | 03 FEB 19

Déficit de sueño y riesgo cardiometabólico

Dormir menos de 7 hs cada noche se asocia con aumento de la morbimortalidad, sobre todo aquella debida a enfermedades cardiovasculares
Autor/a: Tobaldini E, Fiorelli E, Solbiati M, Nature Reviews Cardiology 08 noviembre 2018
INDICE:  1. Página 1 | 2. Referencias bibliográficas
Referencias bibliográficas

1. Watson, N. et al. Recommended amount of sleep for a healthy adult: a joint consensus statement of the American Academy of Sleep Medicine and Sleep Research Society. J. Clin. Sleep Med. 11, 931–952 (2015).

2. Hirshkowitz, M. et al. National Sleep Foundation’s updated sleep duration recommendations: final report. Sleep Heal. 1, 233–243 (2015).

3. Liu, Y. et al. Prevalence of healthy sleep duration among adults — United States, 2014. MMWR Morb. Mortal. Wkly Rep. 65, 137–141 (2016).

4. Grandner, M. A., Patel, N. P., Gehrman, P. R., Perlis, M. L. & Pack, A. I. Problems associated with short sleep: bridging the gap between laboratory and epidemiological studies. Sleep Med. Rev. 14,239–247 (2010).

5. Wheaton, A. G., Jones, S. E., Cooper, A. C. & Croft, J. B. Short sleep duration among middle school and high school students — United States, 2015. MMWR Morb. Mortal. Wkly Rep. 67, 85–90 (2018).

6. Schutte-rodin, S. et al. Clinical guideline for the evaluation and management of chronic insomnia in adults. J. Clin. Sleep Med. 4, 487–504 (2008).

7. Young, T. et al. The occurrence of sleep-disordered breathing among middle-aged adults. N. Engl. J. Med. 328, 1230–1235 (1993).

8. Peppard, P. E. et al. Increased prevalence of sleep-disordered breathing in adults. Am. J. Epidemiol. 177, 1006–1014 (2013).

9. Heinzer, R. et al. Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study. Lancet Respir. Med. 3, 310–318 (2015).

10. Chin, K. et al. Associations between obstructive sleep apnea, metabolic syndrome, and sleep duration, as measured with an actigraph, in an urban male working population in Japan. Sleep 33, 89–95 (2010).

11. Vgontzas, A. N. et al. Insomnia with short sleep duration and mortality: the Penn State cohort. Hypertension 33, 1159–1164 (2010).

12. Vgontzas, A. N., Fernandez-Mendoza, J., Liao, D. & Bixler, E. O. Insomnia with objective short sleep duration: the most biologically severe phenotype of the disorder. Sleep Med. Rev. 17, 241–254 (2013).

13. Ren, R. et al. Objective but not subjective short sleep duration is associated with hypertension in obstructive sleep apnea. Hypertension 72, 610–617 (2018).

14. Priou, P. et al. Cumulative association of obstructive sleep apnea severity and short sleep duration with the risk for hypertension. PLOS ONE 9, 1–12 (2014).

15. Tobaldini, E. et al. Sleep, sleep deprivation, autonomic nervous system and cardiovascular diseases. Neurosci. Biobehav. Rev. 74, 321–329 (2017).

16. Li, X. et al. U-shaped relationships between sleep duration and metabolic syndrome and metabolic syndrome components in males: a prospective cohort study. Sleep Med. 16, 949–954 (2015).

17. Kim, J. Y. et al. A prospective study of total sleep duration and incident metabolic syndrome: the ARIRANG study. Sleep Med. 16, 1511–1515 (2015).

18. Gottlieb, D. J. et al. Association of sleep time with diabetes mellitus and impaired glucose tolerance. Arch. Intern. Med. 165, 863–867 (2005).

19. Wu, Y., Zhai, L. & Zhang, D. Sleep duration and obesity among adults: a meta-analysis of prospective studies. Sleep Med. 15, 1456–1462 (2014).

20. Sabanayagam, C. & Shankar, A. Sleep duration and cardiovascular disease: results from the National Health Interview Survey. Sleep 33, 1037–1042 (2010).

21. Sauvet, F. et al. Effect of acute sleep deprivation on vascular function in healthy subjects. J. Appl. Physiol. 108, 68–75 (2010).

22. Tobaldini, E. et al. One night on-call: sleep deprivation affects cardiac autonomic control and inflammation in physicians. Eur. J. Intern. Med. 24, 664–670 (2013).

23. Zhong, X. et al. Increased sympathetic and decreased parasympathetic cardiovascular modulation in normal humans with acute sleep deprivation. J. Appl. Physiol. 98, 2024–2032 (2005).

24. Dettoni, J. L. et al. Cardiovascular effects of partial sleep deprivation in healthy volunteers. J. Appl. Physiol. 113, 232–236 (2012).

25. Takase, B. et al. Effects of chronic sleep deprivation on autonomic activity by examining heart rate variability, plasma catecholamine, and intracellular magnesium levels. Biomed. Pharmacother. 58, 35–39 (2004).

26. Grimaldi, D., Carter, J. R., Van Cauter, E. & Leproult, R. Adverse impact of sleep restriction and circadian misalignment on autonomic function in healthy young adults. Hypertension 68, 243–250 (2016).

27. Spiegel, K., Leproult, R. & Van Cauter, E. Impact of sleep debt on metabolic and endocrine function. Lancet 354, 1435–1439 (1999).

28. Neufeld, E. V., Carney, J. J., Dolezal, B. A., Boland, D. M. & Cooper, C. B. Exploratory study of heart rate variability and sleep among emergency medical services shift workers. Prehospital Emerg. Care 21, 18–23 (2017).

29. Chung, M. et al. Recovery after three-shift work: relation to sleep-related cardiac neuronal regulation in nurses. Ind. Health 1, 24–30 (2012).

30. Su, T. C. et al. Elevated blood pressure, decreased heart rate variability and incomplete blood pressure recovery after a 12-hour night shift work. J. Occup. Health 50, 380–386 (2008).

31. Yamasaki, F., Schwartz, J. E., Gerber, L. M., Warren, K. & Pickering, T. G. Impact of shift work and race/ ethnicity on the diurnal rhythm of blood pressure and catecholamines. Hypertension 32, 417–423 (1998).

32. Irwin, M. R. Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation. Arch. Intern. Med. 166, 1756 (2006).

33. Irwin, M. R., Witarama, T., Caudill, M., Olmstead, R. & Breen, E. C. Sleep loss activates cellular inflammation and signal transducer and activator of transcription (STAT) family proteins in humans. Brain. Behav. Immun. 47, 86–92 (2015).

34. Sauvet, F. et al. Vascular response to 1 week of sleep restriction in healthy subjects. A metabolic response? Int. J. Cardiol. 190, 246–255 (2015).

35. Vgontzas, A. N. et al. Circadian interleukin-6 secretion and quantity and depth of sleep.

J. Clin. Endocrinol. Metab. 84, 2603–2607 (1999).

36. Meier-Ewert, H. K. et al. Effect of sleep loss on C-Reactive protein, an inflammatory marker of cardiovascular risk. J. Am. Coll. Cardiol. 43, 678–683 (2004).

37. van Leeuwen, W. M. A. et al. Sleep restriction increases the risk of developing cardiovascular diseases by augmenting proinflammatory responses through IL-17 and CRP. PLOS ONE 4, e4589 (2009).

38. Ferrie, J. E. et al. Associations between change in sleep duration and inflammation: findings on C-reactive protein and interleukin 6 in the Whitehall II study. Am. J. Epidemiol. 178, 956–961 (2013).

39. Miller, M. a et al. Gender differences in the cross-sectional relationships between sleep duration and markers of inflammation: Whitehall II study. Sleep 32, 857–864 (2009).

40. Faraut, B., Boudjeltia, K. Z., Vanhamme, L. & Kerkhofs, M. Immune, inflammatory and

cardiovascular consequences of sleep restriction and recovery. Sleep Med. Rev. 16, 137–149 (2012).

41. Boudjeltia, K. et al. Temporal dissociation between myeloperoxidase (MPO)-modified LDL and MPO elevations during chronic sleep restriction and recovery in healthy young men. PLOS ONE 6, e28230 (2011).

42. Weil, B. R. et al. Short sleep duration is associated with enhanced endothelin-1 vasoconstrictor tone. Can. J. Physiol. Pharmacol. 88, 777–781 (2010).

43. Nakazaki, C. et al. Association of insomnia and short sleep duration with atherosclerosis risk in the elderly. Am. J. Hypertens. 25, 1149–1155 (2012).

44. Matthews, K. A., Dahl, R. E., Owens, J. F., Lee, L. & Hall, M. Sleep duration and insulin resistance in healthy black and white adolescents. Sleep 35, 1353–1358 (2012).

45. Rodrigues, De. Bernardi A. M. et al. Association of sleep deprivation with reduction in insulin sensitivity as assessed by the hyperglycemic clamp technique in adolescents. JAMA Pediatr. 170, 487–494 (2016).

46. Reynolds, A. C. et al. Impact of five nights of sleep restriction on glucose metabolism, leptin and testosterone in young adult men. PLOS ONE 7, e41218 (2012).

47. Donga, E. et al. Partial sleep restriction decreases insulin sensitivity in type 1 diabetes. Diabetes Care 33, 1573–1577 (2010).

48. Francesco, T., Peverini, F., De Benedetto, M. & De Nuccio, F. Obstructive sleep apnea syndrome: blood viscosity, blood coagulation abnormalities, and early atherosclerosis. Lung 191, 1–7 (2013).

49. Robinson, G. V., Pepperell, J. C. T., Segal, H. C., Davies, R. J. O. & Stradling, J. R. Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials. Thorax 59, 777–783 (2004).

50. Kondo, Y. et al. Significant relationship between platelet activation and apnea-hypopnea index in patients with obstructive sleep apnea syndrome. Tokai J. Exp. Clin. Med. 36, 79–83 (2011).

51. Von Känel, R. et al. Association between polysomnographic measures of disrupted sleep and prothrombotic factors. Chest 131, 733–739 (2007).

52. Libby, P. Inflammation and cardiovascular disease mechanisms. Am. J. Clin. Nutr. 83, 456–460 (2006).

53. Visser, M., Bouter, L. M., Mcquillan, G. M., Wener, M. H. & Harris, T. B. Elevated C-reactive protein levels in overweight and obese adults. JAMA 282, 2131–2135 (1999).

54. Danesh, J. et al. Fibrin D-dimer and coronary heart disease prospective study and meta-analysis. Circulation 103, 2323–2327 (2001).

55. Kim, H. C. et al. Multimarker prediction of coronary heart disease risk. J. Am. Coll. Cardiol. 55, 2080–2091 (2010).

56. Münzel, T. et al. Impact of oxidative stress on the heart and vasculature: Part 2 of a 3-Part series. J. Am. Coll. Cardiol. 70, 212–229 (2017).

57. Itani, O., Jike, M., Watanabe, N. & Kaneita, Y. Short sleep duration and health outcomes: a systematic review, meta-analysis, and metaregression. Sleep Med. 32, 246–256 (2017).

58. Chien, K.-L. et al. Habitual sleep duration and insomnia and the risk of cardiovascular events and all-cause death: report from a community-based cohort. Sleep 33, 177–184 (2010).

59. Campanini, M. Z. et al. Agreement between sleep diary and actigraphy in a highly educated Brazilian population. Sleep Med. 35, 27–34 (2017).

60. Lockley, S. W., Skene, D. J. & Arendt, J. Comparison between subjective and actigraphic measurement of sleep and sleep rhythms. J. Sleep Res. 8, 175–183

(1999).

61. Arora, T., Broglia, E., Pushpakumar, D., Lodhi, T. & Taheri, S. An investigation into the strength of the association and agreement levels between subjective and objective sleep duration in adolescents. PLOS ONE 8, 1–6 (2013).

62. Girschik, J., Fritschi, L., Heyworth, J. & Waters, F. Validation of self-reported sleep against actigraphy. J. Epidemiol. 22, 462–468 (2012).

63. Ross, R. Atherosclerosis — An inflammatory disease. N. Engl. J. Med. 340, 115–126 (1999).

64. Willerson, J. T. Inflammation as a cardiovascular risk factor. Circulation 109, II2–10 (2004).

65. Vgontzas, A. N. et al. Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. J. Clin. Endocrinol. Metab. 89, 2119–2126 (2004).

66. Orshal, J. M. & Khalil, R. a. Interleukin-6 impairs endothelium-dependent NO-cGMP-mediated relaxation and enhances contraction in systemic vessels of pregnant rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286, R1013–R1023 (2004).

67. Gangwisch, J. E. et al. Short sleep duration as a risk factor for hypertension: analyses of the first National Health and Nutrition Examination survey. Hypertension 47, 833–839 (2006).

68. Cappuccio, F. P. et al. Gender-specific associations of short sleep duration with the Whitehall II study. Hypertension 50, 693–700 (2007).

69. Knutson, K. L. et al. Association between sleep and blood pressure in midlife. Arch. Intern. Med. 169, 1055 (2009).

70. Ridker, P. M. C-reactive protein and the prediction of cardiovascular events among those at intermediate risk moving an inflammatory hypothesis toward consensus. J. Am. Coll. Cardiol. 49, 2129–2138 (2007).

71. Albert, C. M., Ma, J., Rifai, N., Stampfer, M. J. & Ridker, P. M. Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death. Circulation 105, 2595–2599 (2002).

72. Danesh, J. et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N. Engl. J. Med. 350, 1387–1397 (2004).

73. Calvin, A. D. et al. Experimental sleep restriction causes endothelial dysfunction in healthy humans. J. Am. Heart Assoc. 3, 1–7 (2014).

74. Pongratz, G. & Straub, R. H. The sympathetic nervous response in inflammation. Arthritis Res. Ther. 16, 1–12 (2014).

75. Podrez, E. A., Schmitt, D., Hoff, H. F. & Hazen, S. L. Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro. J. Clin. Invest. 103, 1547–1560 (1999).

76. van Leeuwen, W. M. A. et al. Prolonged sleep restriction affects glucose metabolism in healthy young men. Int. J. Endocrinol. 2010, 108641 (2010).

77. Paneni, F., Diaz Cañestro, C., Libby, P., Lüscher, T. F. & Camici, G. G. The aging cardiovascular system: understanding it at the cellular and clinical levels. J. Am. Coll. Cardiol. 69, 1952–1967 (2017).

78. Miller, M. A., Kandala, N., Kumari, M., Marmot, M. G. & Cappuccio, F. P. Clinical and population studies relationships between sleep duration and von Willebrand factor, factor vii, and fibrinogen Whitehall II study. Arter. Thromb. Vasc. Biol. 30, 2032–2039 (2010).

79. Tosur, Z. et al. The association between sleep characteristics and prothrombotic markers in a population based sample: Chicago area sleep study Sleep Med. 15, 973–978 (2014).

80. Chouchou, F. et al. Sympathetic overactivity due to sleep fragmentation is associated with elevated diurnal systolic blood pressure in healthy elderly subjects: the PROOF-SYNAPSE study. Eur. Heart J. 34, 2122–2131 (2013).

81. Muenter, N. K. et al. Effect of sleep restriction on orthostatic cardiovascular control in humans. J. Appl. Physiol. 88, 966–972 (2000).

82. Sforza, E. et al. Heart rate activation during spontaneous arousals from sleep: effect of sleep deprivation. Clin. Neurophysiol. 115, 2442–2451 (2004).

83. Malliani, A. & Montano, N. Emerging excitatory role of cardiovascular sympathetic afferents in pathophysiological conditions. Hypertension 39, 63–68 (2002).

84. Shen, M. J. & Zipes, D. P. Role of the autonomic nervous system in modulating cardiac arrhythmias. Circ. Res. 114, 1004–1021 (2014).

85. Agarwal, S. K. et al. Cardiac autonomic dysfunction and incidence of atrial fibrillation in a large population-based cohort. J. Am. Coll. Cardiol. 69, 291–299 (2017).

86. Meredith, I. T., Broughton, A., Jennings, G. L. & Esler, M. D. Evidence of a selective increase in cardiac sympathetic activity in patients with sustained ventricular arrhythmias. N. Engl. J. Med. 325, 618–624 (1991).

87. Mancia, G. & Grassi, G. The autonomic nervous system and hypertension. Circ. Res. 114, 1804–1814 (2014).

88. Airaksinen, K. E., Ikaheimo, M. J., Linnaluoto, M. K., Niemela, M. & Takkunen, J. T. Impaired vagal heart rate control in coronary artery disease. Heart 58, 592–597 (1987).

89. Kochiadakis, G. E. et al. Autonomic nervous system activity before and during episodes of myocardial ischemia in patients with stable coronary artery disease during daily life. Pacing Clin. Electrophysiol. 23, 2030–2039 (2000).

90. Huikuri, H. V. et al. Heart rate variability and progression of coronary atherosclerosis.

Arter. Thromb. Vasc. Biol. 19, 1979–1985 (1999).

91. van Bilsen, M. et al. The autonomic nervous system as a therapeutic target in heart failure: a scientific position statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology. Eur. J. Hear. Fail. 19,

1361–1378 (2017).

92. Floras, J. S. & Ponikowski, P. The sympathetic/ parasympathetic imbalance in heart failure with reduced ejection fraction. Eur. Heart J. 36, 1974–1982 (2015).

93. Wang, Y. et al. Chronic sleep fragmentation promotes obesity in young adult mice. Obesity 22, 758–762 (2014).

94. Tracey, K. J. The inflammatory reflex. Nature 420, 853–859 (2002).

95. Itani, O., Kaneita, Y., Murata, A., Yokoyama, E. & Ohida, T. Association of onset of obesity with sleep duration and shift work among Japanese adults. Sleep Med. 12, 341–345 (2011).

 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

AAIP RNBD
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024